Skip to main content
Clinical Trials/KCT0002934
KCT0002934
Completed
未知

Human trial to evaluate the efficacy and safety of Lactobacillus acidophilus NS1 on cholesterol improvement

Inha University Hospital0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Endocrine, nutritional and metabolic disease
Sponsor
Inha University Hospital
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Subject who voluntarily agree to participate and signs informed consent form
  • 2\) Age\=20 years
  • 3\) 200 mg/dL \=Total cholesterol\<240 mg/d

Exclusion Criteria

  • 1\) Subjects who had consistently consumed the drug related to lipid metabolism (ex. statin, ezetimibe, diuretics, fibrate, beta blocker, acetylsalicylic acid, bile acid\-binding resins, etc.) or oriental medicine within 1 month before the first visit, except for the subject who have taken thiazide among the diuretics or beta blockers without change of dose during last one year and expected not to change the dosage during the study period.
  • 2\) Following diseases:
  • \- Familial hypercholesterolemia, past history of myocardial infarction or stroke
  • \- Uncontrolled hypertension (systolic blood pressure \=160 mmHg or diastolic blood pressure \=100 mmHg)
  • \- Uncontrolled diabetes (fasting glucose level \= 180 mg/dL)
  • \- Liver dysfunction (AST, ALT \= 3 X upper limit of normal range)
  • \- Renal dysfunction (serum creatinine \= 1\.4 mg/dL)
  • \- Gastrointestinal disease, autoimmune disease, endocrine disease (hyperthyroidism, hypothyroidism, etc), malignant tumor
  • 3\) Triglyceride \= 300 mg/dL
  • 4\) Women receiving hormone therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials